171 related articles for article (PubMed ID: 38612577)
21. Impaired Autophagy in Intestinal Epithelial Cells Alters Gut Microbiota and Host Immune Responses.
Yang L; Liu C; Zhao W; He C; Ding J; Dai R; Xu K; Xiao L; Luo L; Liu S; Li W; Meng H
Appl Environ Microbiol; 2018 Sep; 84(18):. PubMed ID: 30006408
[TBL] [Abstract][Full Text] [Related]
22. Self-reinoculation with fecal flora changes microbiota density and composition leading to an altered bile-acid profile in the mouse small intestine.
Bogatyrev SR; Rolando JC; Ismagilov RF
Microbiome; 2020 Feb; 8(1):19. PubMed ID: 32051033
[TBL] [Abstract][Full Text] [Related]
23. Dynamic Colonization of Microbes and Their Functions after Fecal Microbiota Transplantation for Inflammatory Bowel Disease.
Chu ND; Crothers JW; Nguyen LTT; Kearney SM; Smith MB; Kassam Z; Collins C; Xavier R; Moses PL; Alm EJ
mBio; 2021 Aug; 12(4):e0097521. PubMed ID: 34281401
[TBL] [Abstract][Full Text] [Related]
24. Gut Microbiota Protected Against
Wen L; Shi L; Kong XL; Li KY; Li H; Jiang DX; Zhang F; Zhou ZG
Front Cell Infect Microbiol; 2022; 12():856633. PubMed ID: 35782123
[TBL] [Abstract][Full Text] [Related]
25. Fecal metabonomics combined with 16S rRNA gene sequencing to analyze the changes of gut microbiota in rats with kidney-yang deficiency syndrome and the intervention effect of You-gui pill.
Chen R; Wang J; Zhan R; Zhang L; Wang X
J Ethnopharmacol; 2019 Nov; 244():112139. PubMed ID: 31401318
[TBL] [Abstract][Full Text] [Related]
26. An Autoimmunogenic and Proinflammatory Profile Defined by the Gut Microbiota of Patients With Untreated Systemic Lupus Erythematosus.
Chen BD; Jia XM; Xu JY; Zhao LD; Ji JY; Wu BX; Ma Y; Li H; Zuo XX; Pan WY; Wang XH; Ye S; Tsokos GC; Wang J; Zhang X
Arthritis Rheumatol; 2021 Feb; 73(2):232-243. PubMed ID: 33124780
[TBL] [Abstract][Full Text] [Related]
27. The Diversity of Gut Microbiome is Associated With Favorable Responses to Anti-Programmed Death 1 Immunotherapy in Chinese Patients With NSCLC.
Jin Y; Dong H; Xia L; Yang Y; Zhu Y; Shen Y; Zheng H; Yao C; Wang Y; Lu S
J Thorac Oncol; 2019 Aug; 14(8):1378-1389. PubMed ID: 31026576
[TBL] [Abstract][Full Text] [Related]
28. Gut microbiota and metabolite variations in a migraine mouse model.
Wang D; Liu X; Shi S; Ren T; Wang W
Front Cell Infect Microbiol; 2023; 13():1322059. PubMed ID: 38357211
[TBL] [Abstract][Full Text] [Related]
29. Clinical Efficacy and Gut Microbiota Regulating-Related Effect of Si-Jun-Zi Decoction in Postoperative Non-Small Cell Lung Cancer Patients: A Prospective Observational Study.
He Y; Qi A; Gu Y; Zhang C; Wang Y; Yang W; Bi L; Gong Y; Jiao L; Xu L
Integr Cancer Ther; 2024; 23():15347354241237973. PubMed ID: 38504436
[TBL] [Abstract][Full Text] [Related]
30. A metagenomic study of the gut microbiome in PTB'S disease.
Ding X; Zhou J; Chai Y; Yan Z; Liu X; Dong Y; Mei X; Jiang Y; Lei H
Microbes Infect; 2022 Mar; 24(2):104893. PubMed ID: 34710620
[TBL] [Abstract][Full Text] [Related]
31. Alterations of the Gut Microbiota in Patients with Diabetic Nephropathy.
Zhang L; Wang Z; Zhang X; Zhao L; Chu J; Li H; Sun W; Yang C; Wang H; Dai W; Yan S; Chen X; Xu D
Microbiol Spectr; 2022 Aug; 10(4):e0032422. PubMed ID: 35863004
[TBL] [Abstract][Full Text] [Related]
32. Chronological analysis of the gut microbiome for efficacy of atezolizumab-based immunotherapy in non-small cell lung cancer: Protocol for a multicenter prospective observational study.
Shoji F; Miura N; Tagawa T; Tsukamoto S; Okamoto T; Yamazaki K; Hamatake M; Takeo S
Thorac Cancer; 2022 Oct; 13(19):2829-2833. PubMed ID: 36063818
[TBL] [Abstract][Full Text] [Related]
33. Gut microbiota dysbiosis contributes to the development of hypertension.
Li J; Zhao F; Wang Y; Chen J; Tao J; Tian G; Wu S; Liu W; Cui Q; Geng B; Zhang W; Weldon R; Auguste K; Yang L; Liu X; Chen L; Yang X; Zhu B; Cai J
Microbiome; 2017 Feb; 5(1):14. PubMed ID: 28143587
[TBL] [Abstract][Full Text] [Related]
34. Microbiome and spatially resolved metabolomics analysis reveal the anticancer role of gut Akkermansia muciniphila by crosstalk with intratumoral microbiota and reprogramming tumoral metabolism in mice.
Zhu Z; Cai J; Hou W; Xu K; Wu X; Song Y; Bai C; Mo YY; Zhang Z
Gut Microbes; 2023; 15(1):2166700. PubMed ID: 36740846
[TBL] [Abstract][Full Text] [Related]
35. Disease-Associated Gut Microbiota Reduces the Profile of Secondary Bile Acids in Pediatric Nonalcoholic Fatty Liver Disease.
Yu J; Zhang H; Chen L; Ruan Y; Chen Y; Liu Q
Front Cell Infect Microbiol; 2021; 11():698852. PubMed ID: 34568090
[TBL] [Abstract][Full Text] [Related]
36. Gut microbiota dysbiosis and decreased levels of acetic and propionic acid participate in glucocorticoid-induced glycolipid metabolism disorder.
Zhang Q; Guan G; Liu J; Hu W; Jin P
mBio; 2024 Feb; 15(2):e0294323. PubMed ID: 38226811
[TBL] [Abstract][Full Text] [Related]
37. Depicting the composition of gut microbiota in children with tic disorders: an exploratory study.
Xi W; Gao X; Zhao H; Luo X; Li J; Tan X; Wang L; Zhao JB; Wang J; Yang G; Liu LY; Wang YY; Peng L; Zou LP; Yang Y
J Child Psychol Psychiatry; 2021 Oct; 62(10):1246-1254. PubMed ID: 33738808
[TBL] [Abstract][Full Text] [Related]
38. Altered Fecal Microbiome and Correlations of the Metabolome with Plasma Metabolites in Dairy Cows with Left Displaced Abomasum.
Luo Z; Yong K; Luo Q; Du Z; Ma L; Huang Y; Zhou T; Yao X; Shen L; Yu S; Deng J; Ren Z; Zhang Y; Yan Z; Zuo Z; Cao S
Microbiol Spectr; 2022 Dec; 10(6):e0197222. PubMed ID: 36222683
[TBL] [Abstract][Full Text] [Related]
39. Gut microbiota dysbiosis contributes to the development of chronic obstructive pulmonary disease.
Li N; Dai Z; Wang Z; Deng Z; Zhang J; Pu J; Cao W; Pan T; Zhou Y; Yang Z; Li J; Li B; Ran P
Respir Res; 2021 Oct; 22(1):274. PubMed ID: 34696775
[TBL] [Abstract][Full Text] [Related]
40. Gut microbiota dysbiosis with hepatitis B virus liver disease and association with immune response.
Yan F; Zhang Q; Shi K; Zhang Y; Zhu B; Bi Y; Wang X
Front Cell Infect Microbiol; 2023; 13():1152987. PubMed ID: 37201112
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]